Inventor · disambiguated record
Troels Koch
Also filed as: KOCH TROELS
25 granted patents·23 pending applications·1,352 citations·filing 1996–2024
97Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS21SANTARIS PHARMA AS12DAKO AS2ROCHE DIAGNOSTICS GMBH2ARKA HOLDING APS1
Top patents by PatentIndex Score
48 records- 0197US9708614B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Jul 18, 2017·28 cites·36 claims
- 0297US9428534B2Antisense designSANTARIS PHARMA AS·Filed 2013·Granted Aug 30, 2016·46 cites·78 claims
- 0397US7687617B2Oligonucleotides with alternating segments of locked and non-locked nucleotidesSANTARIS PHARMA AS·Filed 2003·Granted Mar 30, 2010·207 cites·26 claims
- 0496US9738894B2Short interfering RNA (siRNA) analoguesROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Aug 22, 2017·55 cites·27 claims
- 0596US7569575B2Synthesis of locked nucleic acid derivativesSANTARIS PHARMA AS·Filed 2003·Granted Aug 4, 2009·282 cites·8 claims
- 0692US9994850B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Jun 12, 2018·4 cites·19 claims
- 0792US6998484B2Synthesis of purine locked nucleic acid analoguesSANTARIS PHARMA AS·Filed 2001·Granted Feb 14, 2006·259 cites·51 claims
- 0891US7153954B2Method for preparation of LNA phosphoramiditesSANTARIS PHARMA AS·Filed 2002·Granted Dec 26, 2006·111 cites·7 claims
- 0989US9045518B2Amino-LNA, thio-LNA and alpha-L-oxy-LNCHRISTENSEN SIGNE M·Filed 2003·Granted Jun 2, 2015·19 cites·19 claims
- 1086US6225052B1Method for determining a nucleic acidROCHE DIAGNOSTICS GMBH·Filed 1997·Granted May 1, 2001·101 cites·19 claims
- 1185US8492390B2Synthesis of locked nucleic acid derivativesDETLEF SORENSEN MADS·Filed 2011·Granted Jul 23, 2013·16 cites·8 claims
- 1284US8084458B2Synthesis of locked nucleic acid derivativesSOERENSEN MADS DETLEF·Filed 2009·Granted Dec 27, 2011·15 cites·13 claims
- 1381US6033784AMethod of photochemical immobilization of ligands using quinonesFiled 1996·Granted Mar 7, 2000·70 cites·34 claims
- 1476US6310179B12-or 3-dimensional geometric structuresDAKO AS·Filed 1998·Granted Oct 30, 2001·24 cites·9 claims
- 1575US9297010B2Short interfering RNA (siRNA) analoguesSANTARIS PHARMA AS·Filed 2014·Granted Mar 29, 2016·2 cites·30 claims
- 1674US8653252B2Short interfering RNA (siRNA) analoguesELMEN JOACHIM·Filed 2004·Granted Feb 18, 2014·14 cites·28 claims
- 1773US6117973APNA monomers with electron donor or acceptorGEORGIA TECH RES INST·Filed 1997·Granted Sep 12, 2000·45 cites·9 claims
- 1872US2018237777A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1971US9951333B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Apr 24, 2018·0 cites·30 claims
- 2071US9890383B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Feb 13, 2018·0 cites·30 claims
- 2170US2014128591A1Antisense designSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2270US2018237778A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 2368US6858726B2Synthesis of allofuranoseSANTARIS PHARMA AS·Filed 2002·Granted Feb 22, 2005·2 cites·16 claims
- 2468US2014194614A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2568US2024368593A1Gapmer oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2024·Application pending·0 cites
- 2666US2014128586A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2766US2016168575A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2865US2016168576A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2964US6388061B1Monomeric building blocks for labeling peptide nucleic acidsDAKO AS·Filed 1998·Granted May 14, 2002·26 cites·35 claims
- 3062US2023002762A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2022·Application pending·0 cites
- 3160US6020132AMethod of analysis using signal amplificationROCHE DIAGNOSTICS GMBH·Filed 1997·Granted Feb 1, 2000·26 cites·23 claims
- 3254US6521744B12- or 3-dimensional geometric structuresPNA DIAGNOSTICS AS·Filed 2000·Granted Feb 18, 2003·0 cites·9 claims
- 3354US2020318103A1Stereodefined sub-motif optimisation methodsROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Application pending·0 cites
- 3453US2020339982A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 3550US2020332289A1Gapmer oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 3649US2018016575A1LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate LinkagesROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 3749US2018112217A1Stereospecific Phosphorothioate LNAROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 3844US2009176977A1Lna modified phosphorothiolated oligonucleotidesELMEN JOACIM·Filed 2007·Application pending·0 cites
- 3943US2003125241A1Therapeutic uses of LNA-modified oligonucleotides in infectious diseasesFiled 2002·Application pending·0 cites
- 4043US2022160870A1Neoantigen engineering using splice modulating compoundsROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 4142US2010062994A1Adenosine Receptor AntagonistsSANTARIS PHARMA AS·Filed 2007·Application pending·0 cites
- 4242US2008249039A1Modified Short Interfering Rna (Modified Sirna)SANTARIS PHARMA AS·Filed 2005·Application pending·0 cites
- 4341US10815481B2Chiral library screenROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Granted Oct 27, 2020·0 cites·14 claims
- 4440US2021221837A1Oligonucleotides comprising a phosphorotrithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 4539US11597926B2ThiophosphoramiditesROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Mar 7, 2023·0 cites·20 claims
- 4638US2021292358A1Oligonucleotides comprising a phosphorotrithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 4736US2002068709A1Therapeutic uses of LNA-modified oligonucleotidesFiled 2000·Application pending·0 cites
- 4835US2008034969A1Air Purification by Electromagnetic Rediation of a Dispersed SystemARKA HOLDING APS·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →